Skip to main content

exPDite-2: A Phase 3 Study to Assess the Efficacy and Safety of Midbrain Dopaminergic Neuronal Cell Therapy (Bemdaneprocel) for Participants With Parkinson's Disease

Clinical Trial Grant
Duke Scholars

Administered By

Neurosurgery

Awarded By

BlueRock Therapeutics LP

Start Date

September 28, 2026

End Date

September 28, 2032
 

Administered By

Neurosurgery

Awarded By

BlueRock Therapeutics LP

Start Date

September 28, 2026

End Date

September 28, 2032